Literature DB >> 17127748

Interactions between progesterone and tumor necrosis factor-alpha in the regulation of primordial follicle assembly.

Eric E Nilsson1, Jacob Stanfield, Michael K Skinner.   

Abstract

Follicle assembly is the process by which groups or "nests" of oocytes break down to form primordial follicles. The size of the primordial follicle pool is the major determinant of the reproductive lifespan of a female. Previously, progesterone (P(4)) has been shown to inhibit follicle assembly, while tumor necrosis factor-alpha (TNFalpha) has been shown to promote the apoptosis that is necessary for follicle assembly. The present study examines how TNFalpha and progesterone interact to regulate primordial follicle assembly. Ovaries were collected from newborn rats and placed in organ culture to examine the actions of P(4) and TNFalpha. P(4) was found to decrease primordial follicle assembly and increase the percentage of unassembled oocytes both in vitro and in vivo. TNFalpha treatment did not change the proportion of assembled follicles in cultured ovaries, but blocked the ability of P(4) to inhibit follicle assembly. Microarray analysis of the ovarian transcriptome revealed that progesterone treatment of the ovaries altered the expression of 513 genes with 132 only expressed after P(4) treatment and 16 only expressed in control ovaries. The majority of genes were up-regulated greater than twofold over control, with a small subset of 16 genes down-regulated. Categories of genes affected by P(4) are described including a group of extracellular signaling factors. The progesterone receptors expressed at the time of follicle assembly included the surface membrane progesterone receptors PGRMC1, PGRMC2, and RDA288. The nuclear genomic P(4) receptor was not expressed at appreciable levels. Progesterone increased the expression of several genes (TANK, NFkappaB, Bcl2l1, and Bcl2l2) involved in a signaling pathway that promotes cell survival and inhibits apoptosis. Observations indicate that P(4) acts through the surface membrane progesterone receptors to regulate primordial follicle assembly, and that TNFalpha can override the inhibitory actions of P(4) on follicle assembly. A major mechanism involved in the actions of P(4) is an increase in cell survival genes and inhibition of the apoptosis pathway. Observations provide insight into the hormonal regulation of primordial follicle assembly and lead to novel approaches to potentially manipulate follicle assembly and reproductive capacity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127748      PMCID: PMC8260010          DOI: 10.1530/REP-06-0045

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  38 in total

1.  Characterization of a putative membrane receptor for progesterone in rat granulosa cells.

Authors:  J J Peluso; G Fernandez; A Pappalardo; B A White
Journal:  Biol Reprod       Date:  2001-07       Impact factor: 4.285

Review 2.  Development of follicles in the mammalian ovary.

Authors:  A N Hirshfield
Journal:  Int Rev Cytol       Date:  1991

3.  Progesterone mediates its anti-mitogenic and anti-apoptotic actions in rat granulosa cells through a progesterone-binding protein with gamma aminobutyric acidA receptor-like features.

Authors:  J J Peluso; A Pappalardo
Journal:  Biol Reprod       Date:  1998-05       Impact factor: 4.285

4.  Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion.

Authors:  S J Richardson; V Senikas; J F Nelson
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

Review 5.  Regulation of baboon fetal ovarian folliculogenesis by estrogen.

Authors:  Gerald J Pepe; Reinhart B Billiar; Eugene D Albrecht
Journal:  Mol Cell Endocrinol       Date:  2006-01-18       Impact factor: 4.102

6.  Germ cell proliferation and apoptosis in the developing human ovary.

Authors:  N Fulton; S J Martins da Silva; R A L Bayne; R A Anderson
Journal:  J Clin Endocrinol Metab       Date:  2005-05-24       Impact factor: 5.958

Review 7.  The involvement of tumor necrosis factor-alpha (TNF) as an intraovarian regulator of oocyte apoptosis in the neonatal rat .

Authors:  Jennifer L Marcinkiewicz; Sharon K Balchak; Leisa J Morrison
Journal:  Front Biosci       Date:  2002-09-01

8.  Characterization of membrane receptor activity for 17 alpha, 20 beta, 21-trihydroxy-4-pregnen-3-one in ovaries of spotted seatrout (Cynoscion nebulosus).

Authors:  R Patiño; P Thomas
Journal:  Gen Comp Endocrinol       Date:  1990-05       Impact factor: 2.822

9.  Tumor necrosis factor-alpha gene expression in mouse oocytes and follicular cells.

Authors:  H L Chen; J L Marcinkiewicz; M Sancho-Tello; J S Hunt; P F Terranova
Journal:  Biol Reprod       Date:  1993-04       Impact factor: 4.285

10.  Imminent oocyte exhaustion and reduced follicular recruitment mark the transition to acyclicity in aging C57BL/6J mice.

Authors:  R G Gosden; S C Laing; L S Felicio; J F Nelson; C E Finch
Journal:  Biol Reprod       Date:  1983-03       Impact factor: 4.285

View more
  23 in total

Review 1.  Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Front Neuroendocrinol       Date:  2010-07-04       Impact factor: 8.606

2.  17β-estradiol and progesterone regulate multiple progestin signaling molecules in the anteroventral periventricular nucleus, ventromedial nucleus and sexually dimorphic nucleus of the preoptic area in female rats.

Authors:  K A Intlekofer; S L Petersen
Journal:  Neuroscience       Date:  2010-12-24       Impact factor: 3.590

Review 3.  The earliest stages of follicular development: follicle formation and activation.

Authors:  J E Fortune; M Y Yang; W Muruvi
Journal:  Soc Reprod Fertil Suppl       Date:  2010

4.  Notch signaling regulates ovarian follicle formation and coordinates follicular growth.

Authors:  Dallas A Vanorny; Rexxi D Prasasya; Abha J Chalpe; Signe M Kilen; Kelly E Mayo
Journal:  Mol Endocrinol       Date:  2014-02-19

Review 5.  PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.

Authors:  Hannah J Rohe; Ikhlas S Ahmed; Katherine E Twist; Rolf J Craven
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

6.  Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS).

Authors:  Jens Schuster; Teresia Karlsson; Per-Olof Karlström; Inger Sundström Poromaa; Niklas Dahl
Journal:  Reprod Biol Endocrinol       Date:  2010-06-10       Impact factor: 5.211

7.  Induction of ovarian primordial follicle assembly by connective tissue growth factor CTGF.

Authors:  Ryan Schindler; Eric Nilsson; Michael K Skinner
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

8.  Expression of progesterone receptor membrane component-2 within the immature rat ovary and its role in regulating mitosis and apoptosis of spontaneously immortalized granulosa cells.

Authors:  Daniel Griffin; Xiufang Liu; Cindy Pru; James K Pru; John J Peluso
Journal:  Biol Reprod       Date:  2014-07-02       Impact factor: 4.285

9.  Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.

Authors:  Mahmoud Reza Mansouri; Jens Schuster; Jitendra Badhai; Eva-Lena Stattin; Ralf Lösel; Martin Wehling; Birgit Carlsson; Outi Hovatta; Per Olof Karlström; Irina Golovleva; Daniela Toniolo; Silvia Bione; John Peluso; Niklas Dahl
Journal:  Hum Mol Genet       Date:  2008-09-09       Impact factor: 6.150

10.  Antagonism of human adiponectin receptors and their membrane progesterone receptor paralogs by TNFalpha and a ceramidase inhibitor.

Authors:  Brian R Kupchak; Ibon Garitaonandia; Nancy Y Villa; Jessica L Smith; Thomas J Lyons
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.